Neurofibromatosis, Type

Neurofibromatosis Type 2 Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - Novartis, AstraZeneca, GlaxoSmithKline, Ikena, SpringWorks, Vivace, Recursion

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+1(919)321-6187
www.delveinsight.com   

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/neurofibromatosis-type-2-market-to-observe-impressive-growth-by-2032-evaluates-delveinsight--key-companies---novartis-astrazeneca-glaxosmithkline-ikena-springworks-vivace-recursion-301987137.html

en | boerse | 67943184 |